Company Filing History:
1 out of 531 
1 out of 247 Years Active: 2013
Title: **Brenda Maisonneuve: Innovator in Vaccine Development**
Introduction:
Brenda Maisonneuve, based in Federal Way, WA, is a notable inventor recognized for her contributions to vaccine development. With a focus on advancing medical science, she has been instrumental in creating solutions to combat chlamydial infections.
Latest Patents:
Brenda Maisonneuve holds a patent for "Vaccines against chlamydial infection." This invention involves compositions comprising proteins or polynucleotides of specific strains, particularly focusing on the combinations of these proteins or polynucleotides. The methods are designed for the treatment, prevention, and diagnosis of chlamydial infections, showcasing her expertise in biomedical innovation.
Career Highlights:
Throughout her career, Brenda has contributed significantly to the field of immunology and vaccine development. Her work has been highly regarded, particularly through her association with prestigious organizations. She has worked with GlaxoSmithKline Biologicals and Corixa Corporation, where she honed her skills and expanded her knowledge in vaccine research and development.
Collaborations:
Brenda has collaborated with other prominent figures in the field, including Mark R. Alderson and Ajay Bhatia. These partnerships have fostered a collaborative environment that is essential in scientific research and innovation, allowing them to tackle complex challenges in vaccine development.
Conclusion:
Brenda Maisonneuve stands out as an influential inventor in the world of biomedical innovation. Through her pioneering patent and her contributions to various companies, she has made significant strides in the fight against infectious diseases. Her work not only reflects her dedication to scientific advancement but also her impact on public health through innovative vaccine solutions.